Biolase (BIOL) Reports Q1 Loss of $0.06
Tweet
Share
E-mailGet Alerts BIOL Hot Sheet
Join SI Premium – FREE
Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.06), versus ($0.07) reported last year. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $13.23 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Allegion plc (ALLE) Tops Q1 EPS by 8c ; Offers Guidance
- Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
